Hypotensive effect of prekallikrein activator (PKA) in plasma protein fraction (PPF).
D001794:Blood Pressure; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005174:Factor XII / Q000633:toxicity*; D015956:Factor XIIa; D006801:Humans; D007022:Hypotension / Q000209:etiology*; D010446:Peptide Fragments / Q000633:toxicity*; D010952:Plasma Substitutes / Q000009:adverse effects*; D011897:Random Allocation; D013997:Time Factors; D014655:Vascular Resistance
D010446:Peptide Fragments; D010952:Plasma Substitutes; D005174:Factor XII; D015956:Factor XIIa